CSIR constituent lab CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has developed a cost effective process using locally available chemicalsto synthesize this Active Pharmaceutical Ingredient (API) and transferred the technology to l... See more
A shift towards dry swab testing will immediately entail a saving of up to ?75 crore a day. CSIR-Centre for Cellular and Molecular Biology (CCMB) has asserted that the the current testing capacity of two lakh tests a day across the country can be See more
Council of Scientific & Industrial Research (CSIR), in collaboration with Laxai Life Sciences Pvt. Ltd. Hyderabad, has sought regulatory approval to undertake four-arm randomized controlled phase III clinical trial. The design principle of the study is to rationally combine and repurpose antivirals (viral-entry and replicatio... See more
The Institute of Himalayan Bio-Resource Technology (IHBT) at Palampur in Himachal Pradesh has been playing pivotal role in undertaking COVID-19 tests, besides providing all necessary instruments and logistic support for test of COVID-19 to Tanda, Chamba and Hamirpur Medical Colleges of the state. See more
The National Chemical Laboratory (NCL) along with its Venture Centre incubated startup Genrich Membrane has tied up with the 'Bharat Electronics Ltd' (BEL) company to manufacture the 'Oxygen Enrichment Units' (OEU) which provide 35 to 40 per cent oxygen concentration from air and helps faster recovery of Covid-19 aff... See more
CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow, has received permission for carrying out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drug Umifenovir. The Phase III Clinical Trials will be carried out at Kin... See more
AarogyaPath(www.aarogyapath.in), a National Healthcare Supply Chain Portal is now LIVE. This was launched today by OSD to MoH&FW Shri Rajesh Bhushan in presence of DG CSIR, Dr.VijayChauthiawale, Pharma Sector Expert and JS MSME Mr. Sudhir Garg were Guests of Honour. See more
CSIR is uniquely placed as an S&T organization to deliver these at this critical juncture, having proven expertise in sequencing (first human genome sequencing), diagnostics for rare genetic diseases and being the fountain head of generic industry in the country.
CSIR has advantageously positioned itself to pursue the focused R&D to develop, integrate, scale-up, and deploy necessary technological interventions for combating Coronavirus pandemic in the country. Considering the multifarious problems created by coronavirus which require interventions in several areas and multi-pronged strategy, CSIR has set up five technology verticals for addressing the emerging situation due to pandemic.
These verticals are need based and span multiple research labs and disciplines and draw upon the strength of scientists, students and harness it for the fight against COVID-19. In addition, CSIR is also working on promoting rural employment and providing ready to eat food to migrants and other outreach programs.
Including digital methods: to understand the genetic basis and develop strategy to combat COVID-19
Rapid and economical Diagnostics: Kits based on DNA and serological basis to diagnose the virus at an early stage
Development of new therapies, including repurposing of drugs and new drugs: Vaccine development
Cheap Hospital assistive devices and Personal Protective Equipment (PPE)
Supply chain management and logistics with regard to availability of materials and resources.
CSIR being aware that the task is formidable and cannot be accomplished alone, is working in close synergy with other government departments, ministries and agencies on one hand and on the other is hand with Industry, MSMEs and others for scale up, delivery and implementation.
CSIR is working with various industries to develop technologies and products to fight against COVID-19. View all the Technologies & Products
A dynamic forum for exchanging views, opinions, experiences, and popular insights into developments, technologies & techniques related to COVID-19. Goto CSIR Covid19 Blog
CSIR calls for R&D Proposals from Industry and Start Ups under NMITLI Scheme for breakthrough technological interventions against COVID-19
List of projects selected against CSIR-NMITLI Call for Proposals for tackling COVID-19 Click here
CSIR's Societal Programs for mitigating Coronavirus Pandemic
Promoting Rural Entrepreneurship and Employment - with support from industry
distributed and transferred technology of making reusable face masks
produced and distributed hand sanitizers and disinfectants
Recent videos showcasing CSIR's work on COVID-19
An Overview of Rational Drug Design by Dr. Shekhar Mande, DG CSIR and Secretary, DSIR
'Swasth Vayu' Non invasive ventilator for COVID 19 patients
DG CSIR Highlights CSIRs Fight Against Covid19
DG CSIR talking about CSIR initiatives in the fight against Covid19
Covid-19 vaccine update - India's CSIR testing anti leprosy Mw vaccine
CSIRs big success on Corona Testing Kit
CSIR has its presence across India in the form of 38 laboratories working in difference technologies and sector. More details can be sought on CSIR website
Council of Scientific & Industrial Research,
Anusandhan Bhawan, 2,
Rafi Ahmed Kidwai Marg,
New Delhi 110 001
rpsingh@csir.res.in
